AlphaYou
Overview
Smart money at a glance
Filings to Oct 6, 2026Net buying: insiders sold $0 and bought $30K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- +$30K netNet buying
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 6- Open
- $9.44
- 52-wk high
- $27.40
- High
- $10.38
- 52-wk low
- $6.27
- Low
- $9.16
- Prev close
- $9.38
- Mkt cap
- $84.0M
- Volume
- 27.8K
- Beta
- -0.25
- P/S
- 4016.2x
- P/B
- 2.4x
- Profit margin
- +0.0%
- Op margin
- +0.0%
- ROE
- -172.3%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about PMN filings
Are insiders buying or selling ProMIS Neurosciences Inc. (PMN) stock?
Net buying: insiders sold $0 and bought $30K of PMN stock on the open market in the 90 days to Oct 6, 2026, according to SEC Form 4 filings. The largest was Kaplan, Johanne (Chief Development Officer), who bought $30K. The latest filing was on Aug 7, 2026.
Which members of Congress have traded PMN recently?
None. No member of Congress disclosed a PMN trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this PMN smart-money data?
This summary uses filings available on Oct 6, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
1 fund holds a position and insiders have been net buying.
What insiders are doing
Buys (2)
- KJ
Kaplan Johanne
$30K
bought
- KP
Kirwin Patrick D.
$45K
bought
How top traders are positioned
No tracked top-trader positions in PMN right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in $1.06 a share below what analysts expected.
Last report
May 12, 2026
Period ending
Mar 31, 2026
Earnings per share
-$0.20 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Mar 31, 2026 | May 12, 2026 | -$1.26 / -$0.20Alpha Vantage | -$1.06 miss | Unavailable | Unavailable |
| Dec 31, 2025 | Mar 25, 2026 | -$30.05 / -$6.71Alpha Vantage | -$23.34 miss | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 12, 2025 | -$8.40 / -$9.99Alpha Vantage | +15.92% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 13, 2025 | -$9.98 / -$6.04Alpha Vantage | -65.23% miss | Unavailable | Unavailable |
| Mar 31, 2025 | May 12, 2025 | -$7.35 / -$4.30Alpha Vantage | -70.93% miss | Unavailable | Unavailable |
| Dec 31, 2024 | Mar 31, 2025 | $0.12 / -$0.16Alpha Vantage | +$0.28 beat | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 14, 2024 | $10.86 / -$2.42Alpha Vantage | +$13.28 beat | Unavailable | Unavailable |
| Jun 30, 2024 | Aug 8, 2024 | -$4.47 / -$4.85Alpha Vantage | +7.84% beat | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 11, 2026, in 36 days
Financials
Is the business strong?
This company is running thin margins.
- Net margin
- 0.0%
- Market cap
- $84M
Valuation
- P/S4016.22
- P/B2.41
Quality
- Operating margin0.0%
- ROE-172.3%
- ROA-81.1%
Growth
- Beta-0.25
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace